reviewJournal of Hematology & OncologyJan 21, 2022GOLD OA

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

Zhejiang University · Zhejiang University-University of Edinburgh Institute · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

Abstract RNA demethylase ALKBH5 takes part in the modulation of N 6 -methyladenosine (m 6 A) modification and controls various cell processes. ALKBH5-mediated m 6 A demethylation regulates gene expression by affecting multiple events in RNA metabolism, e.g., pre-mRNA processing, mRNA decay and translation. Mounting evidence shows that ALKBH5 plays critical roles in a variety of human malignancies, mostly via post-transcriptional regulation of oncogenes or tumor suppressors in an m 6 A-dependent manner. Meanwhile, increasing non-coding RNAs are recognized as functional targets of ALKBH5 in cancers. Here we reviewed up-to-date findings about the pathological roles of ALKBH5 in cancer, the molecular mechanisms by…

Citation impact

246
total citations
FWCI
19.23
Percentile
100%
References
201
Citations per year

Authors

8

Topics & keywords

Keywords
  • Demethylase
  • RNA
  • Hematology
  • Cancer research
  • Biology
  • Medicine
  • Internal medicine
  • Pharmacology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding